FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)

View source ↗

Summary

FDA approved a supplemental application for BUTRANS (buprenorphine) from Purdue Pharma LP. This constitutes an additional regulatory action on the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• BUTRANS (Buprenorphine)

Snippet

SUPPL AP for BUTRANS (BUPRENORPHINE)